OOIR: Observatory of International Research

Papers

(The median citation count of Medical Oncology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.	51
In-vitro analysis on the potential use of dental pulp mesenchymal stem cells on arecoline-induced oral epithelial cells	41
Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs	40
Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group	35
Sarcoid-like reaction in cases treated by checkpoint inhibitors	29
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal’s letter	26
Investigation of the Osteopontin isoforms expression in patients with acute myeloid leukemia	24
Metabolic shift of chronic myeloid leukemia patients under imatinib–pioglitazone regimen and discontinuation	21
Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine	21
Comparative expression analysis of dasatinib and ponatinib-regulated lncRNAs in chronic myeloid leukemia and their network analysis	21
Resistin increases cisplatin-induced cytotoxicity in lung adenocarcinoma A549 cells via a mitochondria-mediated pathway	21
Computational study on novel natural inhibitors targeting BCL2	21
Identification of molecular heterogeneity of hepatocellular carcinoma based on immune gene expression signatures	20
Systematic identification of the cancer pathways and molecules related with breast cancer immunogenicity	19
Protein interacting with C-kinase 1 is involved in epithelial-mesenchymal transformation and suppresses progress of gastric cancer	19
Elevated LINC01550 induces the apoptosis and cell cycle arrest of melanoma	19
A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways	18
Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis	17
Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma	17
Vaccination of cancer patients against COVID-19: towards the end of a dilemma	16
Oncotype DX testing does not affect clinical practice in stage IIa colon cancer	16
Identification of key genes in the tumor microenvironment of lung adenocarcinoma	16
Effects of electroporation on anticancer activity of 5-FU and newly synthesized zinc(II) complex in chemotherapy-resistance human brain tumor cells	16
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance	16
Exosomes and cancer: from molecular mechanisms to clinical applications	15

Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools	15
The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer	15
Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model	14
Application of comprehensive bioinformatics approaches to reconnoiter crucial genes and pathways underpinning hepatocellular carcinoma: a drug repurposing endeavor	14
The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies	13
Hypofractionated whole-breast radiotherapy in large breast size patients: is it really a resolved issue?	13
Cancer induced bone pain: current management and future perspectives	13
The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors	13
Correction to: Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes	12
Correction to: The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma	12
Cancer stem cell characteristics and their potential as therapeutic targets	12
CD44-positive cancer stem cells from oral squamous cell carcinoma exhibit reduced proliferation and stemness gene expression upon adipogenic induction	12
Cancer stem cells in colorectal cancer and the association with chemotherapy resistance	12
The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma	12
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a mu	11
Adoptive cell therapy of patient-derived renal cell carcinoma xenograft model with IL-15-induced γδT cells	11
PSMA: a game changer in the diagnosis and treatment of advanced prostate cancer	11
Combined evaluation of proliferation and apoptosis to calculate IC50 of VPA-induced PANC-1 cells and assessing its effect on the Wnt signaling pathway	11
Balstilimab and other immunotherapy for recurrent and metastatic cervical cancer	11
Lipid droplet evolution gives insight into polyaneuploid cancer cell lipid droplet functions	11
Who should be treated with pembrolizumab in addition to standard of care in advanced cervical cancer?	11
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma?	11
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radio	11
COVID-19 pandemic: a new cause of unplanned interruption of radiotherapy in breast cancer patients	10
How should we manage non-small-cell lung cancer “not-otherwise-specified”?	10
Immunotherapy and predictive immunologic profile: the tip of the iceberg	10
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives	10
The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer	10
Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies	10
Oncology: etymology of the term	10
Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy	10
The immunomodulatory effects of Candida albicans isolated from the normal gastrointestinal microbiome of the elderly on colorectal cancer	10
Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer	9
Forward to a methodological proposal to support cancer patients: the dialogics’ contribution for the precision care	9
Role of Src/FAK in migration and invasion mediated by extracellular vesicles from MDA-MB-231 cells stimulated with linoleic acid	9
High KIFC1 expression is associated with poor prognosis in prostate cancer	9
The role of inflammatory indices in the outcome of COVID-19 cancer patients	9
The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas	9
Disease spectrum of gastric cancer susceptibility genes	9
Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma	9
Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer	9
Detection of human papillomavirus infection in oral cancers reported at dental facility: assessing the utility of FFPE tissues	9
Novel therapeutic strategies and perspectives for pancreatic cancer: Autophagy and apoptosis are key mechanisms to fight pancreatic cancer	8
Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltration	8
ERVs-TLR3-IRF axis is linked to myelodysplastic syndrome pathogenesis	8
Ambient air emissions of endocrine-disrupting metals and the incidence of hormone receptor- and HER2-dependent female breast cancer in USA	8
Transcription factors linked to the molecular signatures in the development of hepatocellular carcinoma on a cirrhotic background	8
Is there any place for novel agents in treating biliary tract cancer?	8
The function of Cav-1 in MDA-MB-231 breast cancer cell migration and invasion induced by ectopic ATP5B	8
Tamoxifen in breast cancer survivors with COVID 19: stop or go?	8

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial	8
How to ensure uninterrupted treatment of radiotherapy patients during delta variants of SARS-CoV-2 virus epidemic: the latest experience from Xi’an, China	8
PARP inhibitors: shifting the paradigm in the treatment of pancreatic cancer	8
Bevacizumab in combination with paclitaxel and platinum for previously treated advanced thymic epithelial tumors	8
Interferon regulatory factor-1 regulates cisplatin-induced apoptosis and autophagy in A549 lung cancer cells	8
Correction to: Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway	7
Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions	7
Bioymifi, a novel mimetic of TNF-related apoptosis-induced ligand (TRAIL), stimulates eryptosis	7
Triple-arm androgen blockade for advanced prostate cancer: a review	7
N-Myc promotes angiogenesis and therapeutic resistance of prostate cancer by TEM8	7
Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line	7
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro	7
Major impact of COVID-19 national containment on activities in the French northern comprehensive cancer center	7
The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma	7
A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer	7
The effects of chemotherapeutic drugs on PD-L1 gene expression in breast cancer cell lines	7
An updated review of epidemiology, risk factors, and management of male breast cancer	7
SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer	7
The effect of metformin when combined with neoadjuvant chemotherapy in breast cancer patients	7
Nicaraven prevents the fast growth of inflamed tumors by an anti-inflammatory mechanism	7
Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer	6
The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 si	6
DNA methylation marker to estimate ovarian cancer cell fraction	6
SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling	6
Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial	6
In silico bioinformatics analysis for identification of differentially expressed genes and therapeutic drug molecules in Glucocorticoid-resistant Multiple myeloma	6
WAC, a novel GBM tumor suppressor, induces GBM cell apoptosis and promotes autophagy	6
Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/ NF-κB signaling pathway in C6 glioma cells	6
Short-term outcomes of risk-adapted upfront docetaxel administration in patients with metastatic hormone-sensitive prostate cancer: a multicenter prospective study in Japan	6
Detection of mutations in CML patients resistant to tyrosine kinase inhibitor: imatinib mesylate therapy	6
Letter to the editor regarding "A prospective double-blind randomized trial on ultrasound-guided versus blind intra-articular corticosteroid injections for primary frozen shoulder"	6
Direct oral anticoagulants in cancer patients: which help from the specialist hemostasis and thrombosis laboratory?	6
DNMT1 and miRNAs: possible epigenetics footprints in electromagnetic fields utilization in oncology	6
Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel	6